scispace - formally typeset
X

Xiaoyuan Chen

Researcher at National University of Singapore

Publications -  1270
Citations -  115993

Xiaoyuan Chen is an academic researcher from National University of Singapore. The author has contributed to research in topics: Photothermal therapy & Medicine. The author has an hindex of 149, co-authored 994 publications receiving 89870 citations. Previous affiliations of Xiaoyuan Chen include Brown University & University of Southern California.

Papers
More filters
Journal ArticleDOI

Long-Acting Release Formulation of Exendin-4 Based on Biomimetic Mineralization for Type 2 Diabetes Therapy.

TL;DR: A potent long-acting release system based on biomimetic mineralization was constructed for biocompatible and sustained exendin-4 delivery and can serve as a promising candidate for future clinical applications for type 2 diabetes therapies.
Journal ArticleDOI

Preclinical lymphatic imaging

TL;DR: In this review, a comprehensive summary of in vivo imaging modalities for detecting lymphatic vessels, lymphatic drainage, and lymphatic nodes are provided, which include conventional lymphatic imaging techniques such as dyes and radionuclide scintigraphy as well as novel techniques for lymphatic Imaging using lymphatic biomarkers, photoacoustic imaging, and combinations of multiple modalities.
Journal ArticleDOI

Magnetic/Fluorescent Barcodes Based on Cadmium-Free Near-Infrared-Emitting Quantum Dots for Multiplexed Detection

TL;DR: In this article, a single-wavelength encoding combined with size encoding is used to produce different optical codes by simply changing the wavelength and the intensity of the QDs as well as the size of the barcode microspheres.
Journal ArticleDOI

Rapid and Simple One-Step F-18 Labeling of Peptides

TL;DR: A novel one-step ¹⁸F radiolabeling strategy for peptides that contain a specific arene group is developed, which shortens reaction time and labor significantly, requires low amount of precursor, and results in specific activity of 79 ± 13 GBq/μmol.
Journal ArticleDOI

Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors

TL;DR: The construct described here, EB-PSMA-617, may improve the radiotherapeutic efficacy for patients with PSMA-positive tumors by reducing both the amount of activity needed for therapy as well as the frequency of administration, as compared to PSma-617.